Helmut R Maecke Selected Research

Urea (Carbamide)

1/2017

Radiochemistry and Preclinical PET Imaging of 68Ga-Desferrioxamine Radiotracers Targeting Prostate-Specific Membrane Antigen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Helmut R Maecke Research Topics

Disease

60	Neoplasms (Cancer) 10/2023 - 02/2002
16	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2018 - 05/2002
8	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 10/2003
3	Brain Neoplasms (Brain Tumor) 10/2023 - 12/2011
3	Glioblastoma (Glioblastoma Multiforme) 10/2023 - 06/2006
3	Glioma (Gliomas) 10/2023 - 06/2006
3	Insulinoma 07/2020 - 01/2016
2	Diabetes Mellitus 01/2017 - 01/2017
2	Meningioma (Meningiomas) 10/2016 - 02/2015
2	Breast Neoplasms (Breast Cancer) 01/2016 - 12/2011
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2011 - 12/2011
2	Carcinoma (Carcinomatosis) 02/2011 - 07/2005
2	Neoplasm Metastasis (Metastasis) 01/2008 - 10/2003
1	Astrocytoma (Pilocytic Astrocytoma) 10/2023
1	Oligodendroglioma 10/2023
1	Congenital Hyperinsulinism 07/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2016
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2016
1	Lymphoma (Lymphomas) 01/2016
1	Gastrinoma 01/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2014
1	Necrosis 11/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2013
1	Ovarian Neoplasms (Ovarian Cancer) 12/2011
1	medullary Thyroid cancer 04/2011
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2009
1	Thyroid Neoplasms (Thyroid Cancer) 05/2009

Drug/Important Bio-Agent (IBA)

21	Somatostatin Receptors (Somatostatin Receptor)IBA 10/2016 - 02/2002
19	Peptides (Polypeptides)IBA 10/2023 - 01/2004
18	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2018 - 02/2002
15	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 10/2023 - 01/2005
14	Bombesin Receptors (Bombesin Receptor)IBA 01/2019 - 09/2004
12	BombesinIBA 08/2015 - 09/2004
11	Radioisotopes (Radionuclides)IBA 06/2015 - 02/2002
9	Peptide Receptors (Peptide Receptor)IBA 06/2015 - 04/2007
7	AcidsIBA 06/2009 - 09/2004
6	LigandsIBA 01/2016 - 04/2008
6	Octreotide (Sandostatin)FDA LinkGeneric 10/2010 - 01/2005
5	yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acidIBA 10/2023 - 01/2005
5	Edotreotide (SMT 487)IBA 03/2017 - 02/2002
4	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017 - 08/2009
4	DOTA-Tyr(3)- 90Y-octreotideIBA 01/2017 - 08/2005
4	3-Tyr-octreotideIBA 05/2009 - 01/2005
3	Substance PIBA 10/2023 - 06/2006
3	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 01/2018 - 01/2015
3	Cholecystokinin B ReceptorIBA 06/2015 - 04/2011
3	edotreotide lutetium LU-177IBA 02/2015 - 08/2005
3	IntegrinsIBA 11/2014 - 08/2011
3	GastrinsIBA 12/2011 - 11/2008
2	somatostatin receptor 2IBA 03/2017 - 03/2012
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2016
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2017 - 01/2016
2	Immunoconjugates (Immunoconjugate)IBA 01/2016 - 07/2005
2	DOTA(0)-Tyr(3)- 177Lu-octreotideIBA 02/2015 - 08/2005
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2014 - 12/2011
2	Arginine (L-Arginine)FDA Link 11/2014 - 12/2011
2	Aspartic Acid (Aspartate)FDA Link 11/2014 - 12/2011
2	DOTA-PEG(4)-bombesin (7-14)IBA 02/2011 - 08/2007
2	Ga(III)-DOTATOCIBA 01/2011 - 02/2002
2	Pentetic Acid (DTPA)FDA LinkGeneric 01/2005 - 09/2004
1	RadiopharmaceuticalsIBA 10/2023
1	Capsules (Microcapsules)IBA 10/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 07/2020
1	Exenatide (Byetta)FDA Link 07/2020
1	Urea (Carbamide)FDA LinkGeneric 01/2017
1	AntigensIBA 01/2017
1	Estrogens (Estrogen)FDA Link 01/2016
1	Progesterone FDA LinkGeneric 01/2016
1	Brentuximab VedotinIBA 01/2016
1	Copper-64IBA 08/2015
1	alanyltyrosineIBA 08/2015
1	minigastrinIBA 06/2015
1	EstersIBA 01/2015
1	Bevacizumab (Avastin)FDA Link 11/2014
1	Angiogenesis InhibitorsIBA 11/2014
1	IncretinsIBA 06/2014
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 06/2014
1	GelatinIBA 06/2014
1	gastric inhibitory polypeptide receptorIBA 06/2014
1	Serine Proteases (Serine Protease)IBA 06/2014
1	n-hexadecaneIBA 01/2014
1	glycylhistidineIBA 01/2014
1	Rituximab (Mabthera)FDA Link 07/2013
1	A-factor (Streptomyces)IBA 05/2012
1	Folic Acid (Vitamin M)FDA LinkGeneric 05/2012
1	Folic Acid AntagonistsIBA 05/2012
1	Pemetrexed (MTA)FDA Link 05/2012
1	aspartic acid glycine arginineIBA 08/2011
1	Glutamic Acid (Glutamate)FDA Link 04/2011
1	AndrogensIBA 02/2011
1	pasireotideIBA 10/2010
1	AntibodiesIBA 09/2009
1	IodineIBA 05/2009
1	Thyroglobulin FDA Link 05/2009

Therapy/Procedure

28	Therapeutics 10/2023 - 02/2002
14	Radiotherapy 01/2014 - 02/2002
3	Aftercare (After-Treatment) 01/2017 - 08/2005
2	Catheters 10/2023 - 12/2011
2	Radioimmunotherapy 07/2013 - 07/2005
1	Intravenous Injections 06/2009